Mohamed Abdelghani

Past President at Clinical TMS Society

Mohamed Abdelghani has a diverse work experience in the field of psychiatry and neuromodulation. Mohamed is currently involved with Clinical TMS Society, where they have held multiple leadership roles such as President, Immediate Past President, Director, Vice President, and Secretary. Additionally, they are a member of the Board of Directors for the Foundation for the Advancement of Clinical TMS. In 2020, they founded and became the director of the London TMS Centre, a private medical center specializing in neuromodulation treatments for mental health and neurological conditions. Mohamed also has experience as a Director at Dyad Medical and as a Consultant Psychiatrist at Camden and Islington NHS Foundation Trust. Furthermore, they are the founder and director of DM Practice Management. Prior to these roles, they worked as a Locum Consultant Psychiatrist, Specialist Registrar, and SHO at the South London and Maudsley NHS Foundation Trust. Mohamed started their career as a Clinical Research Worker at the Institute of Psychiatry and as an SHO at Mersey Care NHS Trust and Birmingham and Solihull Mental Health NHS Foundation Trust.

Mohamed Abdelghani holds a Master's Degree in Psychiatry from King's College London, which they obtained from 2010 to 2011. Prior to that, they pursued a degree in Psychiatry and obtained MRCPsych from The Royal College of Psychiatrists between 2006 and 2009. Mohamed's educational journey began in 1996 at Ain Shams University, where they completed their Bachelor's Degree in Medicine by 2003.

Location

London, United Kingdom

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Clinical TMS Society

An international medical society dedicated to optimizing clinical practice, supporting research, and increasing access to high quality, evidence-based Transcranial Magnetic Stimulation. As TMS shifted from the research lab to the clinical practice there has been a growing need for an entity that permits providers to collaborate and address the challenges faced by this novel therapy in its formative years. In January 2013, the Clinical TMS Society was established as a 501(c)(6) legal entity. The Society includes TMS providers with extensive clinical and research experience from across the United States and the world. The Society hopes to assist members in optimizing the administration of TMS, develop novel indications for TMS therapy, expand insurance coverage, increase public awareness of TMS, and advertise individual TMS clinics.


Employees

51-200

Links